Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 3, 2008, Pages 687-689

  Durand, Marion ^a,b,c   Lecompte, Thomas ^a,b,c   Hacquard, Marie ^a,b,c   Carteaux, Jean Pierre ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cardiopulmonary bypass; Heparin induced thrombocytopenia; rFVIIa; Tirofiban; Unfractionated heparin

Indexed keywords

DANAPAROID; HEPARIN; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TIROFIBAN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CASE REPORT; CONTINUOUS INFUSION; CORONARY ARTERY BYPASS GRAFT; DRUG WITHDRAWAL; HEART HEMODYNAMICS; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; MITRAL VALVE REPLACEMENT; PHOTOMETRY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANTICOAGULANTS; CARDIOPULMONARY BYPASS; DRUG THERAPY, COMBINATION; FACTOR VIIA; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; REOPERATION; THROMBOCYTOPENIA; TYROSINE;

EID: 49149099945     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.05.029     Document Type: Article

References (10)

1. Kuitunen A., Suojaranta-Ylinen R., Raivio P., Kukkonen S., and Lassila R. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome. J Cardiothorac Vasc Anesth 21 1 (2007) 18-22
2. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 6 (2003) 2121-2131
3. Commin P.L., Rozec B., Trossaert M., Le Teurnier Y., Fournet X., and Blanloeil Y. Use of heparin and platelet GPIIbIIIa inhibitor tirofiban for cardiac surgery in patients for suspicion of heparin-induced thrombocytopenia. Ann Fr Anesth Reanim 25 11-12 (2006) 1153-1157
4. Warren O., Mandal K., Hadjianastassiou V., Knowlton L., Panesar S., John K., Darzi A., and Athanasiou T. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 83 2 (2007) 707-714
5. Tcheng J.E. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment. Am Heart J 139 2 Pt 2 (2000) S38-S45
6. Blanloeil Y., Rigal J.C., Bastien O., Carteaux J.P., Toussaint-Hacquard M., and Lecompte T. Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation (Editorial in French). Ann Fr Anesth Reanim 25 (2006) 2-5
7. von Heymann C., Redlich U., Jain U., Kastrup M., Schroeder T., Sander M., Grosse J., Ziemer S., Koscielny J., Konertz W.F., Wernecke K.D., and Spies C. Recombinant activated factor VII for refractory bleeding after cardiac surgery - a retrospective analysis of safety and efficacy. Crit Care Med 33 10 (2005) 2241-2246
8. Lisman T., Moschatsis S., Adelmeijer J., Nieuwenhuis H.K., and De Groot P.G. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood 101 5 (2003) 1864-1870
9. Poon M.C., D'Oiron R., Von Depka M., Khair K., Négrier C., Karafoulidou A., Huth-Kuehne A., and Morfini M. International Data Collection on Recombinant Factor Vlla and Congenital Platelet Disorders Study Group, Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2 7 (2004) 1096-1103
10. Stepinska J., Banaszewski M., Konopka A., and Szajewski T. Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban. Thromb Haemost 87 2 (2002) 355-356